The introduction of 3D imaging in prostate biopsies has revolutionized how doctors visualize and target suspicious areas within the prostate gland. This advanced technology enables more accurate diagnosis and better treatment planning, ultimately improving patient outcomes and reducing the risk of complications. It allows urologists to pinpoint the precise location of prostate cancer within the gland and better assess the extent of the disease. Numerous studies have shown that this system provides a higher level of diagnostic accuracy for patients at risk of prostate cancer.
There is always a risk that traditional ultrasound may miss small tumors because soft tissues appear with low accuracy in the scan. Additionally, the grid approach used by ultrasound targets the peripheral aspects of the prostate gland, which means it can miss 30-40% of cancers, especially if they are located in the anterior, middle, or apex of the gland. There are also some risks associated with the number of needles used for this type of examination; the more needles used, the more accurate the examination, but the greater the risk of infection and sexual or urinary side effects.
By combining advanced MRI with 3D ultrasound technology, this biopsy system:
3D MRI scans are used for multiparametric MRI. There is no need for an internal rectal coil for the scan (unlike older versions of MRI technology), and the scan has much higher definition than ultrasound. The procedure is non-invasive and allows for a detailed analysis of the entire prostate gland. This means that doctors can get a clear idea of the number of tumors a patient has and how aggressive the cancer is, which could eliminate the need for a biopsy.
Since 3D MRI can identify smaller tumors, it means you get a more accurate diagnosis. Additionally, you can enjoy better treatment if you need a biopsy, as the biopsy can be focused on the high-resolution MRI. The biopsy will target exactly the right tissues, making it less invasive, and healthy tissues will not be sampled. Side effects are rare, and the risk of infection is reduced. The MRI-guided biopsy will target tissues that are most likely to contain cancer only.
Unfortunately, prostate cancer cannot be diagnosed by MRI alone. MRI can give an idea of blood flow, tissue density, and other indicators of cancer risk. Certain characteristics of cancerous tissues can be used to give doctors an idea of whether tissues might be cancerous, but the tissues must be examined closely to determine whether they are cancerous with greater accuracy.
MRI-guided biopsies help ensure that the treatment you receive matches the severity of the condition, saving you from potential infections and long-term side effects. It reduces the risk of missing smaller cancerous areas (which are low-risk but can spread if the cells are aggressive) because they are not overlooked.
3D imaging in prostate biopsies offers significant advantages in terms of improved targeting, diagnostic accuracy, and treatment planning. While considerations such as cost and availability remain important, the benefits of using advanced imaging techniques in diagnosing and treating prostate cancer cannot be overlooked.
” All rights reserved ” Terms of Use and Privacy Policy For Turkey Healthcare Group
Turkey Healthcare Group is one of the largest institutions working in the field of healthcare and international medical consultations in Turkey, where it includes a group of Doctors With experience in their fields in all medical specialties and holders of local and international certificates and awards, who are located in the largest Turkish hospitals spread in Istanbul, where we seek through our qualified and trained medical staff in the most prestigious Turkish and international hospitals to continue to develop.
Our institution provides international healthcare services and medical consultations in all medical specialties, as well as we provide all medical treatments to international patients from all over the world.
“All copyrights reserved” Terms of Use and Privacy Policy to Turkey Healthcare Group 2023